{"ticker": {"uuid": "ce17d919-d920-4cef-bcb4-dcd8e2d681da", "symbol": "LITS", "name": "Lite Strategy, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell Microcap Index", "summary": "Lite Strategy, Inc. (NasdaqCM: LITS) has been added to the Russell Microcap Index, as announced on June 28, 2026. The company, formerly MEI Pharma, Inc., focuses on Litecoin treasury management and developing cancer therapies. This inclusion signifies a notable development for Li", "url": "https://www.marketscreener.com/news/lite-strategy-inc-nasdaqcm-lits-added-to-russell-microcap-index-ce7f5fdcda8ff323", "source_name": "marketscreener.com", "published_at": "2026-06-29T14:40:23", "published_display": "29 Jun 2026 14:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell 3000E Index", "summary": "Lite Strategy, Inc. (NasdaqCM:LITS) has been added to the Russell 3000E Index. The company focuses on accumulating pure Litecoin through active treasury management and aims to concentrate holdings per share as a key metric of shareholder value. This news follows their recent incl", "url": "https://www.marketscreener.com/news/lite-strategy-inc-nasdaqcm-lits-added-to-russell-3000e-index-ce7f5fdedd8cf72c", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T06:09:38", "published_display": "29 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPT2dSR1dxMHcwLTJ5c1Z3WTBZNXlMX3NXSF96NWFtQ0p2NERQZFJQZm81aVhQLWNBVTJ1cU9oMkNnQXFBbkdpV0pNV3cyT2xEMEdJd1lXMjRyZmhodVV0RnZuUXFvbzhLcGhnajBrOVlFSnBQdVBfOGg5YTZTUEt4QjItclZRT0xmNE1NR0g3WFk1ODRKVTloMEJ0MllCc21CaUJyV3dZTWFKbmFCM1o4Q204QkNpR0JOQ3l6QkJFaHo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article displays the enterprise value to revenue forward for Lite Strategy, Inc. (NASDAQ: LITS). It notes that the market is currently closed with no trades. The information is provided by TradingView, sourcing market data from ICE Data Services and reference data from FactS", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:11:34", "published_display": "28 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides the \"Price to sales forward\" financial data for Lite Strategy, Inc. (NASDAQ: LITS). It highlights the period, value, and change metrics for this specific financial ratio. The information is presented within the context of TradingView's market data offerings.", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T13:39:31", "published_display": "27 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides financial data for Lite Strategy, Inc. (LITS) on TradingView, specifically focusing on its Price to Book Forward value. It indicates that the market was closed with no trades recorded at the time of publication. The page also lists various services and discl", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:39:31", "published_display": "27 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides the enterprise value to EBIT forward for Lite Strategy, Inc. (NASDAQ: LITS). It appears to be a financial data snippet from TradingView, focusing on key financial metrics for this pharmaceutical company. The content primarily displays corporate information a", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:38:52", "published_display": "26 Jun 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Flynn James P adds 25,000 Lite Strategy (LITS) shares", "summary": "Lite Strategy, Inc. director Flynn James P an open-market purchase of 25,000 shares of Common Stock, bought at a weighted-average price of $0.8555 per share. Following this transaction, he directly holds 125,000 Lite Strategy shares. This transaction signals insider confidence in", "url": "https://www.stocktitan.net/sec-filings/LITS/form-4-lite-strategy-inc-insider-trading-activity-42dcaf84556f.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:21", "published_display": "25 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Inc Actuals & Estimates (NASDAQ:LITS)", "summary": "This article provides an overview of Lite Strategy, Inc. (NASDAQ: LITS) stock performance, financial estimates, and key statistics. It covers details like current stock price, volatility, market capitalization, and upcoming earnings reports, along with historical high and low pri", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T19:11:06", "published_display": "25 Jun 2026 19:11", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy invests $1M in LitVM to enable smart contracts on Litecoin", "summary": "Lite Strategy, a Nasdaq-listed company, has invested $1 million in ZK Innovations, the developer of LitVM, to bring smart contracts and DeFi capabilities to Litecoin. LitVM aims to build a Layer-2 zero-knowledge platform that will introduce scalability and Ethereum compatibility ", "url": "https://pluang.com/en/news-feed/lite-strategy-pimpin-investasi-1juta-litvm-bawa-smart-contract-litecoin", "source_name": "Pluang", "published_at": "2026-06-19T22:10:57", "published_display": "19 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc. to Join Litecoin Foundation Summit Panel on Litecoin\u2019s Institutional Opportunity", "summary": "Lite Strategy, Inc. (Nasdaq: LITS), the first U.S. public company to adopt Litecoin as its primary treasury reserve asset, will participate in a panel at the Litecoin Foundation Summit 2026 in Amsterdam. The panel, featuring Litecoin creator Charlie Lee and GSR's Joshua Riezman, ", "url": "https://www.quiverquant.com/news/Lite+Strategy%2C+Inc.+to+Join+Litecoin+Foundation+Summit+Panel+on+Litecoin%E2%80%99s+Institutional+Opportunity", "source_name": "Quiver Quantitative", "published_at": "2026-06-19T12:40:00", "published_display": "19 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam", "summary": "Lite Strategy, Inc. (Nasdaq: LITS), the first U.S. public company to adopt Litecoin as its primary treasury reserve asset, announced its participation in a featured panel at the Litecoin Foundation Summit in Amsterdam. This marks the first time a NASDAQ-listed digital asset treas", "url": "https://www.globenewswire.com/news-release/2026/06/19/3314726/0/en/lite-strategy-to-attend-panel-at-litecoin-foundation-summit-in-amsterdam.html", "source_name": "GlobeNewswire", "published_at": "2026-06-19T08:30:00", "published_display": "19 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVM", "summary": "Lite Strategy, the first U.S. public company to hold Litecoin as its primary treasury reserve asset, has led a $1 million strategic investment in ZK Innovations Inc., the developer of LitVM. LitVM is a zero-knowledge Layer 2 platform built on Litecoin, aiming to introduce smart c", "url": "https://finance.yahoo.com/markets/crypto/articles/exclusive-lite-strategy-leads-1m-114513759.html", "source_name": "Market source", "published_at": "2026-06-18T16:45:00", "published_display": "18 Jun 2026 16:45", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy invests $1M in Litecoin layer 2 developer By Investing.com", "summary": "Lite Strategy Inc. (NASDAQ:LITS) has invested $1 million in ZK Innovations Inc., the developer of LitVM, a zero-knowledge layer 2 platform for Litecoin. This investment grants Lite Strategy governance participation rights and an option to acquire future LitVM network tokens. The ", "url": "https://m.uk.investing.com/news/stock-market-news/lite-strategy-invests-1m-in-litecoin-layer-2-developer-93CH-4735407?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-18T13:40:00", "published_display": "18 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Leads Strategic Investment in LitVM", "summary": "Lite Strategy (Nasdaq: LITS) has made a strategic $1.0 million investment in ZK Innovations Inc., the developer of LitVM, a zero-knowledge Layer 2 platform for Litecoin. This investment aims to increase Litecoin's utility and functionality by bringing smart contracts and programm", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314172/0/en/lite-strategy-leads-strategic-investment-in-litvm.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T12:09:46", "published_display": "18 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy backs Litecoin Layer 2 LitVM with $1M and governance rights", "summary": "Lite Strategy (Nasdaq: LITS) has invested $1 million in ZK Innovations, the developer of LitVM, a zero-knowledge Layer 2 platform on Litecoin. This strategic investment grants Lite Strategy governance rights and potential future network tokens, aligning its growth with LitVM's ex", "url": "https://www.stocktitan.net/news/LITS/lite-strategy-leads-strategic-investment-in-lit-tdykxsootdqi.html", "source_name": "Stock Titan", "published_at": "2026-06-18T12:09:46", "published_display": "18 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Stock Faces Litecoin Setback", "summary": "Lite Strategy Inc. (NASDAQ: LITS), a crypto-treasury firm, saw its shares rise while its core asset, Litecoin (LTC), declined. The company, which changed its name from MEI Pharma in September 2025 to focus on Litecoin as its main reserve asset, is under scrutiny as a real-world e", "url": "https://www.bez-kabli.pl/lite-strategy-stock-faces-litecoin-setback/", "source_name": "Bez Kabli", "published_at": "2026-06-05T06:10:58", "published_display": "05 Jun 2026 06:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEI Pharma Inc stock (US5846882069): following ticker change to LITS after reverse stock split", "summary": "MEI Pharma Inc. has undergone a 1-for-25 reverse stock split and subsequently changed its Nasdaq ticker from MEIP to LITS, now trading as Lite Strategy. This change reflects the company's continued focus on oncology drug development, with investors assessing the implications of t", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mei-pharma-inc-stock-us5846882069-following-ticker-change-to-lits-after/69467313", "source_name": "Ad Hoc News", "published_at": "2026-06-01T23:09:02", "published_display": "01 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "The article provides information about Lite Strategy, Inc. (NASDAQ: LITS), focusing on its number of shareholders for various periods. It displays financial data and other market-related information sourced from ICE Data Services and FactSet. The content is primarily a data page ", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-15T20:40:02", "published_display": "15 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lite Strategy Reports Fiscal 2026 Third Quarter Results", "summary": "Lite Strategy, Inc. announced its fiscal 2026 third-quarter results, highlighting continued success in generating yield from its Litecoin holdings through a covered call option program and deploying these proceeds along with LTC for share repurchases. The company emphasized its c", "url": "https://www.globenewswire.com/news-release/2026/05/13/3294003/0/en/lite-strategy-reports-fiscal-2026-third-quarter-results.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T06:10:26", "published_display": "14 May 2026 06:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc. 10-Q Report: Financial Information, Market Risk Disclosures, and Management Analysis for 2026", "summary": "Lite Strategy, Inc. has released its Q3 2026 investor report, detailing significant financial changes including a substantial increase in total assets to $57.8 million and a new entry into crypto assets valued at $2.1 million. The report highlights changes in asset composition, i", "url": "https://www.minichart.com.sg/2026/05/13/lite-strategy-inc-10-q-report-financial-information-market-risk-disclosures-and-management-analysis-for-2026/", "source_name": "Minichart", "published_at": "2026-05-13T16:47:31", "published_display": "13 May 2026 16:47", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Reports Q3 2026 Results: Grows Yield on Litecoin Holdings, Expands Share Repurchase Program, and Highlights SEC\u2019s Digital Commodity Guidance 1", "summary": "Lite Strategy, Inc. reported strong Q3 2026 results, highlighting its active treasury management through a covered call options program on Litecoin holdings, which generated $0.7 million. The company is actively executing a share repurchase program, deploying both covered call pr", "url": "https://www.minichart.com.sg/2026/05/13/lite-strategy-reports-q3-2026-results-grows-yield-on-litecoin-holdings-expands-share-repurchase-program-and-highlights-secs-digital-commodity-guidance-1/", "source_name": "Minichart", "published_at": "2026-05-13T13:39:31", "published_display": "13 May 2026 13:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is Lite Strategy (NASDAQ:LITS) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNckNRZ1ZUR2JQTHJUX0hNOHRGTkxlVXFLNnZ4YVlBZUNseWdLS1d4c1FkQ3gwMEUzYkluczZiRURQUWhpbVRjcVRhUnl4R0hvVDRxVWVVSjBsclNaNGF5TmwySlRjWFRSQmhEaUU0amhsUUtxNTlFeHZoNFc4MERvMXlWY0JQT3NSeEN4UC1abmFnSEpkdThGNHpzSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lite Strategy, Inc. (LITS) News, Articles, Events & Latest Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE43RDRQN0RqSjJ1M3RLaWIxekRORUdUdTU3MjhGV3gwRjQtWHBPN0k1Q0NGWEJESGxaMUpmWWVDQTVyTldCVkNjRTI1bzZYZ0N6?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-16T04:13:55+00:00", "published_display": "16 Jan 2026 04:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LITS Stock Price and Chart \u2014 NASDAQ:LITS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5jQVo4M2FnYzFRNkMtcWNjWXBibUFNRWJfTXZvbEl0cmRXZlBxQ2NIeW9aNDZUanhubzBrZlZlczhIN1BZSDNELTROVjNhbENzbllSTGgwbTJhV3I4?oc=5", "source_name": "TradingView", "published_at": "2025-09-11T14:16:17+00:00", "published_display": "11 Sep 2025 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker \u2018LITS\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQR0VZdDFxVGVxRFN1cldvWmVEYVZ1TlJDMXZOYmdfTGJlbkh1MG96Tmp2TjZ1RnVBeVpOMnF6UDNZeG5fSVZpM0htcUplVjQwQVBlaV80MHVCczlDTnl6aGFHOE5EOWRVbVNGMGxKaHZTb0g4akZiZ3VRUE95dDZvX09FX2gxUXp1WkJ0OVJsZGdPd2JsOU5mcXNSNkFVNEpHamJPY0NhbEhyRWJ4V0Zoa3NDNjJyUUtVcEFhckRQTWJCRUNyS0JsXzlNbzJWdw?oc=5", "source_name": "Business Wire", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell Microcap Index", "summary": "Lite Strategy, Inc. (NasdaqCM: LITS) has been added to the Russell Microcap Index, as announced on June 28, 2026. The company, formerly MEI Pharma, Inc., focuses on Litecoin treasury management and developing cancer therapies. This inclusion signifies a notable development for Li", "url": "https://www.marketscreener.com/news/lite-strategy-inc-nasdaqcm-lits-added-to-russell-microcap-index-ce7f5fdcda8ff323", "source_name": "marketscreener.com", "published_at": "2026-06-29T14:40:23", "published_display": "29 Jun 2026 14:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell 3000E Index", "summary": "Lite Strategy, Inc. (NasdaqCM:LITS) has been added to the Russell 3000E Index. The company focuses on accumulating pure Litecoin through active treasury management and aims to concentrate holdings per share as a key metric of shareholder value. This news follows their recent incl", "url": "https://www.marketscreener.com/news/lite-strategy-inc-nasdaqcm-lits-added-to-russell-3000e-index-ce7f5fdedd8cf72c", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T06:09:38", "published_display": "29 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPT2dSR1dxMHcwLTJ5c1Z3WTBZNXlMX3NXSF96NWFtQ0p2NERQZFJQZm81aVhQLWNBVTJ1cU9oMkNnQXFBbkdpV0pNV3cyT2xEMEdJd1lXMjRyZmhodVV0RnZuUXFvbzhLcGhnajBrOVlFSnBQdVBfOGg5YTZTUEt4QjItclZRT0xmNE1NR0g3WFk1ODRKVTloMEJ0MllCc21CaUJyV3dZTWFKbmFCM1o4Q204QkNpR0JOQ3l6QkJFaHo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article displays the enterprise value to revenue forward for Lite Strategy, Inc. (NASDAQ: LITS). It notes that the market is currently closed with no trades. The information is provided by TradingView, sourcing market data from ICE Data Services and reference data from FactS", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:11:34", "published_display": "28 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides the \"Price to sales forward\" financial data for Lite Strategy, Inc. (NASDAQ: LITS). It highlights the period, value, and change metrics for this specific financial ratio. The information is presented within the context of TradingView's market data offerings.", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T13:39:31", "published_display": "27 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides financial data for Lite Strategy, Inc. (LITS) on TradingView, specifically focusing on its Price to Book Forward value. It indicates that the market was closed with no trades recorded at the time of publication. The page also lists various services and discl", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:39:31", "published_display": "27 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "This article provides the enterprise value to EBIT forward for Lite Strategy, Inc. (NASDAQ: LITS). It appears to be a financial data snippet from TradingView, focusing on key financial metrics for this pharmaceutical company. The content primarily displays corporate information a", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:38:52", "published_display": "26 Jun 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Flynn James P adds 25,000 Lite Strategy (LITS) shares", "summary": "Lite Strategy, Inc. director Flynn James P an open-market purchase of 25,000 shares of Common Stock, bought at a weighted-average price of $0.8555 per share. Following this transaction, he directly holds 125,000 Lite Strategy shares. This transaction signals insider confidence in", "url": "https://www.stocktitan.net/sec-filings/LITS/form-4-lite-strategy-inc-insider-trading-activity-42dcaf84556f.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:21", "published_display": "25 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Inc Actuals & Estimates (NASDAQ:LITS)", "summary": "This article provides an overview of Lite Strategy, Inc. (NASDAQ: LITS) stock performance, financial estimates, and key statistics. It covers details like current stock price, volatility, market capitalization, and upcoming earnings reports, along with historical high and low pri", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T19:11:06", "published_display": "25 Jun 2026 19:11", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy invests $1M in LitVM to enable smart contracts on Litecoin", "summary": "Lite Strategy, a Nasdaq-listed company, has invested $1 million in ZK Innovations, the developer of LitVM, to bring smart contracts and DeFi capabilities to Litecoin. LitVM aims to build a Layer-2 zero-knowledge platform that will introduce scalability and Ethereum compatibility ", "url": "https://pluang.com/en/news-feed/lite-strategy-pimpin-investasi-1juta-litvm-bawa-smart-contract-litecoin", "source_name": "Pluang", "published_at": "2026-06-19T22:10:57", "published_display": "19 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc. to Join Litecoin Foundation Summit Panel on Litecoin\u2019s Institutional Opportunity", "summary": "Lite Strategy, Inc. (Nasdaq: LITS), the first U.S. public company to adopt Litecoin as its primary treasury reserve asset, will participate in a panel at the Litecoin Foundation Summit 2026 in Amsterdam. The panel, featuring Litecoin creator Charlie Lee and GSR's Joshua Riezman, ", "url": "https://www.quiverquant.com/news/Lite+Strategy%2C+Inc.+to+Join+Litecoin+Foundation+Summit+Panel+on+Litecoin%E2%80%99s+Institutional+Opportunity", "source_name": "Quiver Quantitative", "published_at": "2026-06-19T12:40:00", "published_display": "19 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam", "summary": "Lite Strategy, Inc. (Nasdaq: LITS), the first U.S. public company to adopt Litecoin as its primary treasury reserve asset, announced its participation in a featured panel at the Litecoin Foundation Summit in Amsterdam. This marks the first time a NASDAQ-listed digital asset treas", "url": "https://www.globenewswire.com/news-release/2026/06/19/3314726/0/en/lite-strategy-to-attend-panel-at-litecoin-foundation-summit-in-amsterdam.html", "source_name": "GlobeNewswire", "published_at": "2026-06-19T08:30:00", "published_display": "19 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVM", "summary": "Lite Strategy, the first U.S. public company to hold Litecoin as its primary treasury reserve asset, has led a $1 million strategic investment in ZK Innovations Inc., the developer of LitVM. LitVM is a zero-knowledge Layer 2 platform built on Litecoin, aiming to introduce smart c", "url": "https://finance.yahoo.com/markets/crypto/articles/exclusive-lite-strategy-leads-1m-114513759.html", "source_name": "Market source", "published_at": "2026-06-18T16:45:00", "published_display": "18 Jun 2026 16:45", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy invests $1M in Litecoin layer 2 developer By Investing.com", "summary": "Lite Strategy Inc. (NASDAQ:LITS) has invested $1 million in ZK Innovations Inc., the developer of LitVM, a zero-knowledge layer 2 platform for Litecoin. This investment grants Lite Strategy governance participation rights and an option to acquire future LitVM network tokens. The ", "url": "https://m.uk.investing.com/news/stock-market-news/lite-strategy-invests-1m-in-litecoin-layer-2-developer-93CH-4735407?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-18T13:40:00", "published_display": "18 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Leads Strategic Investment in LitVM", "summary": "Lite Strategy (Nasdaq: LITS) has made a strategic $1.0 million investment in ZK Innovations Inc., the developer of LitVM, a zero-knowledge Layer 2 platform for Litecoin. This investment aims to increase Litecoin's utility and functionality by bringing smart contracts and programm", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314172/0/en/lite-strategy-leads-strategic-investment-in-litvm.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T12:09:46", "published_display": "18 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy backs Litecoin Layer 2 LitVM with $1M and governance rights", "summary": "Lite Strategy (Nasdaq: LITS) has invested $1 million in ZK Innovations, the developer of LitVM, a zero-knowledge Layer 2 platform on Litecoin. This strategic investment grants Lite Strategy governance rights and potential future network tokens, aligning its growth with LitVM's ex", "url": "https://www.stocktitan.net/news/LITS/lite-strategy-leads-strategic-investment-in-lit-tdykxsootdqi.html", "source_name": "Stock Titan", "published_at": "2026-06-18T12:09:46", "published_display": "18 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Stock Faces Litecoin Setback", "summary": "Lite Strategy Inc. (NASDAQ: LITS), a crypto-treasury firm, saw its shares rise while its core asset, Litecoin (LTC), declined. The company, which changed its name from MEI Pharma in September 2025 to focus on Litecoin as its main reserve asset, is under scrutiny as a real-world e", "url": "https://www.bez-kabli.pl/lite-strategy-stock-faces-litecoin-setback/", "source_name": "Bez Kabli", "published_at": "2026-06-05T06:10:58", "published_display": "05 Jun 2026 06:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEI Pharma Inc stock (US5846882069): following ticker change to LITS after reverse stock split", "summary": "MEI Pharma Inc. has undergone a 1-for-25 reverse stock split and subsequently changed its Nasdaq ticker from MEIP to LITS, now trading as Lite Strategy. This change reflects the company's continued focus on oncology drug development, with investors assessing the implications of t", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mei-pharma-inc-stock-us5846882069-following-ticker-change-to-lits-after/69467313", "source_name": "Ad Hoc News", "published_at": "2026-06-01T23:09:02", "published_display": "01 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Lite Strategy, Inc. \u2013 NASDAQ:LITS", "summary": "The article provides information about Lite Strategy, Inc. (NASDAQ: LITS), focusing on its number of shareholders for various periods. It displays financial data and other market-related information sourced from ICE Data Services and FactSet. The content is primarily a data page ", "url": "https://www.tradingview.com/symbols/NASDAQ-LITS/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-15T20:40:02", "published_display": "15 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Reports Fiscal 2026 Third Quarter Results", "summary": "Lite Strategy, Inc. announced its fiscal 2026 third-quarter results, highlighting continued success in generating yield from its Litecoin holdings through a covered call option program and deploying these proceeds along with LTC for share repurchases. The company emphasized its c", "url": "https://www.globenewswire.com/news-release/2026/05/13/3294003/0/en/lite-strategy-reports-fiscal-2026-third-quarter-results.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T06:10:26", "published_display": "14 May 2026 06:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc. 10-Q Report: Financial Information, Market Risk Disclosures, and Management Analysis for 2026", "summary": "Lite Strategy, Inc. has released its Q3 2026 investor report, detailing significant financial changes including a substantial increase in total assets to $57.8 million and a new entry into crypto assets valued at $2.1 million. The report highlights changes in asset composition, i", "url": "https://www.minichart.com.sg/2026/05/13/lite-strategy-inc-10-q-report-financial-information-market-risk-disclosures-and-management-analysis-for-2026/", "source_name": "Minichart", "published_at": "2026-05-13T16:47:31", "published_display": "13 May 2026 16:47", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy Reports Q3 2026 Results: Grows Yield on Litecoin Holdings, Expands Share Repurchase Program, and Highlights SEC\u2019s Digital Commodity Guidance 1", "summary": "Lite Strategy, Inc. reported strong Q3 2026 results, highlighting its active treasury management through a covered call options program on Litecoin holdings, which generated $0.7 million. The company is actively executing a share repurchase program, deploying both covered call pr", "url": "https://www.minichart.com.sg/2026/05/13/lite-strategy-reports-q3-2026-results-grows-yield-on-litecoin-holdings-expands-share-repurchase-program-and-highlights-secs-digital-commodity-guidance-1/", "source_name": "Minichart", "published_at": "2026-05-13T13:39:31", "published_display": "13 May 2026 13:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Lite Strategy (NASDAQ:LITS) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNckNRZ1ZUR2JQTHJUX0hNOHRGTkxlVXFLNnZ4YVlBZUNseWdLS1d4c1FkQ3gwMEUzYkluczZiRURQUWhpbVRjcVRhUnl4R0hvVDRxVWVVSjBsclNaNGF5TmwySlRjWFRSQmhEaUU0amhsUUtxNTlFeHZoNFc4MERvMXlWY0JQT3NSeEN4UC1abmFnSEpkdThGNHpzSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lite Strategy, Inc. (LITS) News, Articles, Events & Latest Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE43RDRQN0RqSjJ1M3RLaWIxekRORUdUdTU3MjhGV3gwRjQtWHBPN0k1Q0NGWEJESGxaMUpmWWVDQTVyTldCVkNjRTI1bzZYZ0N6?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-16T04:13:55+00:00", "published_display": "16 Jan 2026 04:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LITS Stock Price and Chart \u2014 NASDAQ:LITS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5jQVo4M2FnYzFRNkMtcWNjWXBibUFNRWJfTXZvbEl0cmRXZlBxQ2NIeW9aNDZUanhubzBrZlZlczhIN1BZSDNELTROVjNhbENzbllSTGgwbTJhV3I4?oc=5", "source_name": "TradingView", "published_at": "2025-09-11T14:16:17+00:00", "published_display": "11 Sep 2025 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker \u2018LITS\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQR0VZdDFxVGVxRFN1cldvWmVEYVZ1TlJDMXZOYmdfTGJlbkh1MG96Tmp2TjZ1RnVBeVpOMnF6UDNZeG5fSVZpM0htcUplVjQwQVBlaV80MHVCczlDTnl6aGFHOE5EOWRVbVNGMGxKaHZTb0g4akZiZ3VRUE95dDZvX09FX2gxUXp1WkJ0OVJsZGdPd2JsOU5mcXNSNkFVNEpHamJPY0NhbEhyRWJ4V0Zoa3NDNjJyUUtVcEFhckRQTWJCRUNyS0JsXzlNbzJWdw?oc=5", "source_name": "Business Wire", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 91, "total_relevant": 34, "sentiment_summary": {"positive": 13, "negative": 3, "neutral": 18, "score": 59, "total": 34, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 12}], "positive_events": 13, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 1.01, "latest_week": "2026-07-10", "one_week_move": 6.3, "four_week_move": 36.3, "twelve_week_move": -14.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.081335, "market_dynamics_buy_signal": false, "relative_strength": -59.138524, "fair_value_gap": -67.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.7111, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+6.3% over one week, +36.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 70, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 8}, {"label": "Market source", "count": 7}, {"label": "GlobeNewswire", "count": 3}, {"label": "marketscreener.com", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Minichart", "count": 2}, {"label": "www.marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 26}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 12}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "26", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+6.3% over one week, +36.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Lite Strategy, Inc.(NasdaqCM: LITS) added to Russell Microcap Index"}], "updated_at": "2026-07-16T08:07:08.081703+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}